Fig. 1: GLT8D2 is overexpression in human ovarian cancer with chemoresistance and correlates with progression and poor prognosis.

a The mRNAs expression of GLT8D2 in ovarian cancer tissues (up); Western blotting analysis of GLT8D2 expression in 12 human ovarian cancer tissues, GAPDH was used as a loading control. b IHC staining indicating the GLT8D2 protein expression in platinum sensitive and platinum resistance tumor tissues.